|20.60|| +0.64 / +3.21%|
Services to the Health Industry
Albany Molecular Research, Inc. engages in research and manufacturing organization providing customers drug discovery, development, and manufacturing services. The company operates through three segments: Discovery and Development Services, Active Pharmaceutical Ingredients and Drug Product. The Discovery and Development Services segment provides comprehensive services from hit identification to investigational new drug, including drug lead discovery, library design and synthesis, synthetic and medicinal chemistry, in vitro biology and pharmacology, lead optimization, chemical development, drug metabolism and pharmacokinetics and small-scale commercial manufacturing. The Active Pharmaceutical Ingredients segment includes pilot to commercial scale manufacturing of API, including intermediates and high potency and controlled substance manufacturing. The Drug Product segment includes formulation through commercial scale production of complex liquid-filled and lyophilized parenteral formulations. The company was founded by Thomas E. D'Ambra on June 20, 1991 and is headquartered in Albany, NY.
|William S. Marth||President, Chief Executive Officer & Director|
|Felicia Ladin||Chief Financial Officer, Treasurer & Senior VP|
|Jimmy Wang||Chief Information Officer & Senior Vice President|
|Lori M. Henderson||Secretary, Senior Vice President & General Counsel|
|Richard A. Saffee||Vice President & GM-Large Scale Manufacturing|